USV in talks with Novartis to buy Jalra Trademark for Rs. 200 Crore
Posted by
www.biotecnika.org
Mumbai-based drugmaker USV Pvt Ltd is in advanced discussions to
acquire the trademark for antidiabetes drug Jalra from Novartis for a
deal valued at more than Rs. 200 crore.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usv-in-talks-with-novartis-to-buy-jalra-trademark-for-rs-200-crore/articleshow/72431900.cms
Subscribe to:
Post Comments (Atom)
Post a Comment